Trump administration’s reference pricing proposal gets thumbs-down from BIO CEO panel
Another proposal, to revoke safe-harbor protections under the Anti-Kickback Statute for biopharma-PBM rebates, drew praise from speakers in a panel at the BIO CEO & Investor Conference Tuesday.